-
to Treat Mitochondrial Diseases (LAC-TreatMito-UK) was established in September 2024 to deliver a national platform to translate novel treatment strategies and biomarkers into clinical trials. This platform
-
, the Sisodiya group focuses on understanding complex epilepsies using a multimodal approach, including clinical phenotyping, genomics, imaging, and other methodologies, with an emphasis on translational impact
-
description. Applications without a supporting statement will be rejected. If you have any queries about the role or application process, technical issues, or need reasonable adjustments or a more accessible
-
Close Study Research Engage About Give Work at UCL Home Home Search Jobs Application Process Rewards and Benefits Careers Community People Around UCL Temporary Work UCL Home Work at UCL Search UCL